Skip to content ↓

Resources: News

Categories:
All
Articles
Events
Industry Insights
News
Webinars
White Papers

Latest in News

PAREXEL and SHYFT Analytics Partner to Deliver Faster, More Dynamic Real-World Data Studies

PAREXEL and SHYFT Analytics Partner to Deliver Faster, More Dynamic Real-World Data Studies

PAREXEL and SHYFT Analytics Partner to Deliver Faster, More Dynamic Real-World Data Studies  SHYFT’s leading platform to become PAREXEL’s foundation for outcomes analysis in support of clinical development and commercialization Waltham, Mass. – November 8, 2018 – SHYFT Analytics, a Medidata Solutions (NASDAQ:MDSO) company, and PAREXEL International,…

SHYFT to Develop a Launch Plan for Tetraphase Pharmaceuticals

SHYFT to Develop a Launch Plan for Tetraphase Pharmaceuticals

Priya Sapra, SHYFT’s SVP, Product & Customer Engagement, talks to Pharmaceutical Commerce about SHYFT’s recent selection by Tetraphase Pharmaceuticals to support data and analytics for commercial launch readiness. SHYFT’s Platform will support the anticipated commercial launch of eravacycline, Tetraphase’s  lead antibiotic candidate developed to address multidrug-resistant bacteria.

Novartis Partners with SHYFT to Support its Digital Transformation

Novartis Partners with SHYFT to Support its Digital Transformation

NEW YORK and WALTHAM, Mass – July XX, 2018 — SHYFT Analytics, a Medidata Solutions (NASDAQ: MDSO) company, announced today that Novartis has selected its Intelligent Platform for Life Sciences to support the commercialization of key therapies in Europe. Novartis will use the following SHYFT solutions: STRATA Data…

Tetraphase Pharmaceuticals Selects SHYFT to Support Data and Analytics for Commercial Launch Readiness

Tetraphase Pharmaceuticals Selects SHYFT to Support Data and Analytics for Commercial Launch Readiness

Waltham, Mass. – SHYFT Analytics, recently acquired by Medidata Solutions to create the only Intelligent Platform for Life Sciences, announced Tetraphase Pharmaceuticals has selected its platform to support the anticipated commercial launch of eravacycline, its lead antibiotic candidate developed to address multidrug-resistant bacteria. The launch is subject to…

SHYFT Agrees to Acquisition by Medidata to Define the Future of Life Sciences

SHYFT Agrees to Acquisition by Medidata to Define the Future of Life Sciences

Medidata Defines the Future of Life Sciences with Acquisition of SHYFT Analytics   Leading the digital transformation of life sciences with artificial intelligence and advanced analytics NEW YORK — June 12, 2018 — Medidata (NASDAQ: MDSO) today announced that it has entered into a definitive…

Using Real-World Evidence to Optimize Clinical Trials

Using Real-World Evidence to Optimize Clinical Trials

This pivotal new paper, which you can download HERE, describes how biopharmaceutical companies can better leverage existing real-world data (RWD) to improve the costs and efficiencies of R&D and accelerate the timelines of clinical trials without compromising the quality of evidence development, and instead greatly enhance trial feasibility, implementation,…

SHYFT Debuts New Lumen UI, its Latest Analytics and Data Visualization Platform

SHYFT Debuts New Lumen UI, its Latest Analytics and Data Visualization Platform

WALTHAM, MA – April 30, 2018 – SHYFT Analytics, the leading cloud data analytics provider for life sciences, today announced the launch of Lumen, its newest data visualization platform. Developed for both clinical and commercial teams, Lumen uses advanced data-driven analytical and visual information design to empower users to…

SHYFT Announces Promotion of Priya Sapra to Chief Operating Officer

SHYFT Announces Promotion of Priya Sapra to Chief Operating Officer

SHYFT Analytics, the leading data and analytics cloud for life sciences, today announced that Priya (Bhargava) Sapra has been named Chief Operating Officer and Chief Product Officer. Priya is part of SHYFT’s executive team and oversees Product Innovation for SHYFT’s award winning platform. Her role will expand to include…

SHYFT Selected as a Top 100 Digital Tech Company in Boston

SHYFT Selected as a Top 100 Digital Tech Company in Boston

SHYFT is honored to be named one of the top 100 digital tech companies in Boston today, not only because we’re a tech company being listed alongside giants like MathWorks and TripAdvisor, but because we play in a sector that has been at the heart of…

Six New Companies Select SHYFT to Launch Their Specialty and Rare Disease Brands

Six New Companies Select SHYFT to Launch Their Specialty and Rare Disease Brands

SHYFT Analytics, the leading data and analytics cloud for life sciences, today announced that in the last quarter, six biopharma companies have chosen to launch their new therapies using the SHYFT Platform. The number of SHYFT Launch customers has increased 50% year over year propelled by the company’s uniquely…